Endoscopic and histologic outcome in tofacitinib treated refractory moderate-to-severe ulcerative colitis: A prospective real-life cohort

被引：0
|
作者：
Verstockt, B. [1 ]
Outtier, A. [1 ]
Lefrere, J. [1 ]
Sabino, J. [1 ]
Vermeire, S. [1 ]
De Hertogh, G. [2 ]
Ferrante, M. [2 ]
机构：
[1] Univ Hosp Leuven, IBD Leuven, Dept Gastroenterol & Hepatol, Leuven, Belgium
[2] Univ Hosp Leuven, Lab Morphol & Mol Pathol, IBD Leuven, Leuven, Belgium
来源：
JOURNAL OF CROHNS & COLITIS | 2020年 / 14卷
关键词：
D O I：
暂无
中图分类号：
R57 [消化系及腹部疾病];
学科分类号：
摘要：
P399
引用
收藏
页码：S369 / S370
页数：2
相关论文
共 50 条
  • [1] ENDOSCOPIC AND HISTOLOGIC OUTCOME IN TOFACITINIB TREATED REFRACTORY MODERATE-TO-SEVERE ULCERATIVE COLITIS: A PROSPECTIVE REAL-LIFE COHORT
    Verstockt, Bram
    Outtier, An
    Lefrere, Jolien
    Sabino, Joao
    Vermeire, Severine
    De Hertogh, Gert
    Ferrante, Marc
    GASTROENTEROLOGY, 2020, 158 (06) : S952 - S952
  • [2] Initial experience of tofacitinib for treating refractory moderate-to-severe ulcerative colitis
    Nakamura, Masanao
    Yamamura, Takeshi
    Maeda, Keiko
    Sawada, Tsunaki
    Mizutani, Yasuyuki
    Ishikawa, Eri
    Ishikawa, Takuya
    Kakushima, Naomi
    Furukawa, Kazuhiro
    Ohno, Eizaburo
    Kawashima, Hiroki
    Honda, Takashi
    Ishigami, Masatoshi
    Fujishiro, Mitsuhiro
    NAGOYA JOURNAL OF MEDICAL SCIENCE, 2022, 84 (01): : 169 - 179
  • [3] Real-life efficacy and safety of tofacitinib to treat moderate- to-severe ulcerative colitis in Switzerland
    Schoepfer, Alain
    Michetti, Pierre
    Biedermann, Luc
    Seibold, Frank
    SWISS MEDICAL WEEKLY, 2023, 153 : 3S - 3S
  • [4] Real-life experience with the use of Tofacitinib in Colombian patients with moderate to severe Ulcerative Colitis: a descriptive study
    Izquierdo, L. V. Parra
    Frias-Ordonez, J.
    Marquez, J. R.
    Juliao-Banos, F.
    Galindo, P.
    Cuadros, C.
    Rojas, C.
    Rojas, N.
    Ardila, O.
    Tovar-Fierro, G.
    Garcia-Duperly, R.
    Parada, F. L. Gil
    Acosta, P. L. Imbeth
    Puentes, F. E.
    de Sanchez, M. T. Galiano
    de Ardila, A. Hani
    Florez-Sarmiento, C.
    JOURNAL OF CROHNS & COLITIS, 2023, 17 : 863 - 865
  • [5] Efficacy of tofacitinib for the treatment of moderate-to-severe ulcerative colitis: real-world data
    Xiao, Y.
    Lakatos, P. L.
    Bourdages, R.
    Bitton, A.
    Afif, W.
    Kohen, R.
    Berberi, M.
    Bessissow, T.
    JOURNAL OF CROHNS & COLITIS, 2020, 14 : S445 - S445
  • [6] Characteristics of patients with moderate-to-severe ulcerative colitis treated with vedolizumab: results from a Polish multicenter, prospective, observational real-life study (the POLONEZ study)
    Cichoz-Lach, Halina
    Michalak, Agata
    Kopertowska-Majchrzak, Maria
    Eder, Piotr
    Stawczyk-Eder, Kamila
    Waszak, Katarzyna
    Talar-Wojnarowska, Renata
    Zatorski, Hubert
    Solarska-Polchlopek, Anna
    Chmielnicki, Jaroslaw
    Filip, Rafal
    Pekala, Anna
    Janiak, Maria
    Skrobot, Krzysztof
    Kasinska, Ewa
    Krogulecki, Michal
    Krolikowski, Piotr
    Klopocka, Maria
    Liebert, Ariel
    Poniewierka, Elzbieta
    Smola, Izabela
    Gasiorowska, Anita
    Kaczka, Aleksandra
    Wypych, Joanna
    Wojciechowski, Krzysztof
    Drygala, Szymon
    Zagorowicz, Edyta
    THERAPEUTIC ADVANCES IN GASTROENTEROLOGY, 2021, 14
  • [7] One year endoscopic and histologic outcomes to tofacitinib therapy in refractory ulcerative colitis
    Verstockt, B.
    Aden, K.
    Alsoud, D.
    Outtier, A.
    Sabino, J.
    Rosenstiel, P.
    Vermeire, S.
    De Hertogh, G.
    Schreiber, S.
    Ferrante, M.
    JOURNAL OF CROHNS & COLITIS, 2021, 15 : S456 - S457
  • [8] ONE YEAR ENDOSCOPIC AND HISTOLOGIC OUTCOMES TO TOFACITINIB THERAPY IN REFRACTORY ULCERATIVE COLITIS
    Verstockt, Bram
    Alsoud, Dahham
    Outtier, An
    Sabino, Joao
    Vermeire, Severine
    De Hertogh, Gert
    Ferrante, Marc
    GASTROENTEROLOGY, 2021, 160 (06) : S702 - S702
  • [9] Initial 8-week Therapy with Tofacitinib in Moderate-to-Severe Ulcerative Colitis in a Real World Prospective Multicenter Study (TOUR)
    Long, Millie D.
    Afzali, Anita
    Fisher, Monika
    English, Emily
    Zhang, Xian
    Hudesman, David
    Abdalla, Maisa
    McCabe, Robert P.
    Cohen, Benjamin
    Harlan, William
    Hanson, John
    Konijeti, Gauree G.
    Polyak, Steven
    Ritter, Timothy E.
    Salzberg, Bruce
    Herfarth, Hans
    AMERICAN JOURNAL OF GASTROENTEROLOGY, 2021, 116 : S440 - S441
  • [10] Efficacy and safety of tofacitinib in patients with moderate-to-severe ulcerative colitis: A real-world retrospective study
    Yoshimura, N.
    Okano, Soh
    Sako, Minako
    Takazoe, Masakazu
    JOURNAL OF CROHNS & COLITIS, 2020, 14 : S545 - S545
12345